Neurostimulation Devices Market Is Expected To Reach $18.71 Billion By 2032

10-Dec-2024 | Zion Market Research

Zion Market Research has published a new report titled “Neurostimulation Devices Market by Product (Deep Brain Stimulation Devices, Spinal Cord Stimulation Devices, Gastric Electric Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, and Others), by Application (Parkinson’s Disease, Epilepsy, Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Alzheimer’s, Ischemia, and Others), and by End-User (Hospitals, Scientific Research Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032”. The global Neurostimulation Devices market size accrued earnings worth approximately USD 6.48 Billion in 2023 and is predicted to gain revenue of about USD 18.71 Billion by 2032, is set to record a CAGR of nearly 12.5% over the period from 2024 to 2032.

Global Neurostimulation Devices Market

New technologies are being developed and researches have been revealing more potential uses of this treatment. This, in turn, is fuelling the rising demand for safer and cost-effective treatment options. Moreover, the increasing prevalence of diseases that are treated with neurostimulation therapy is the major growth factor of the global neurostimulation devices market. In addition, the increasing number of FDA approvals for clinical trials in this area is also propelling the global neurostimulation devices market.

However, the lack of well-trained professionals and non-measurable outcomes are affecting the growth of the neurostimulation devices market globally. Alternatively, the need to provide safe and improved care to patients suffering from neurological disorders and government support in emerging countries are expected to generate new market opportunities over the forecast time period.

Browse the full “Neurostimulation Devices Market by Product (Deep Brain Stimulation Devices, Spinal Cord Stimulation Devices, Gastric Electric Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, and Others), by Application (Parkinson’s Disease, Epilepsy, Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Alzheimer’s, Ischemia, and Others), and by End-User (Hospitals, Scientific Research Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032” Report at https://www.zionmarketresearch.com/report/neurostimulation-devices-market

Global Neurostimulation Devices Market

The global neurostimulation devices market is segmented on the basis of product, application, and end-user. Based on product, the neurostimulation devices market is classified into deep brain stimulation devices, gastric electric stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and others. Spinal cord stimulation devices dominated the market in 2018 and are likely to show the highest CAGR in the future. This can be attributed to its wide applications in pain management and high market penetration due to commercially available products. The use of deep brain stimulator devices for Tourette syndrome, Alzheimer’s, cluster headache, refractory epilepsy trigeminal neuralgia, and movement disorders by multiple sclerosis are awaiting FDA approval, which will boost the market growth for these devices globally.

On the basis of application, the market is segmented into epilepsy, Parkinson's disease, pain management, essential tremor, urinary and fecal incontinence, Alzheimer’s, ischemia, and others. The pain management segment dominated the market in 2018, due to the rising prevalence rate of chronic disorders and growing neurostimulation devices adoption for pain management owing to its high therapeutic value. Parkinson’s disease is also likely to grow notably in the future, owing to the growing geriatric population base and low availability of treatment options for this disease type. As per the WHO, depression is the leading cause of ill health globally. Estimates have suggested that more than 500 million individuals suffer from depression worldwide, with an increase of over 20% between 2005 and 2015.

Based on end-user, the market includes hospitals, scientific research laboratories, and others. The increasing prevalence of neurological diseases is fuelling the growth of the hospital segment globally.

By region, North America is anticipated to dominate the global neurostimulation devices market and hold a major market share in the future. The European neurostimulation devices market is likely to hold a major share in the future, due to the cost-effectiveness of clinical researches in the region, which is enabling the medical devices companies to introduce new devices in the market. In emerging markets like India, about 31 million people suffer from neurological disorders with the prevalence of around 2,500 patients per 10,000 patients. This is further boosting the neurostimulation devices market in the Asia Pacific region.

Some leading players of the global neurostimulation devices market include Boston Scientific Corporation, Medtronic Inc., Cyberonics Inc., NeuroPace Inc., St. Jude Medical Inc., and NeuroSigma, Inc.

This report segments the global neurostimulation devices market into:

Global Neurostimulation Devices Market: Product Analysis

  • Deep Brain Stimulation Devices
  • Spinal Cord Stimulation Devices
  • Gastric Electric Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Others

Global Neurostimulation Devices Market: Application Analysis

  • Parkinson’s Disease
  • Epilepsy
  • Pain Management
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Alzheimer’s
  • Ischemia
  • Others

Global Neurostimulation Devices Market: End-User Analysis

  • Hospitals
  • Scientific Research Laboratories
  • Others

Global Neurostimulation Devices Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed